| 
 Plenary 
            Speaker
 Natural Products -- An Exciting Source 
            of New Drugs and Pharmacophores
 Atta-ur-Rahman and M. Iqbal Choudhary
 Pakistan
 
 
 Two third of the world’s population relies on natural remedies 
            for primary health care and the global annual sale of botanicals is 
            over $ 80 billion. These two statistics reflect the importance of 
            natural products in health and economy. Access to reliable ethnomedicinal 
            knowledge, combined with modern tools of research such as LC-MS/MS, 
            LC-NMR, LC-MS/NMR, etc., and high-throughput screening protocols are 
            greatly facilitating the process of drug discovery from natural sources.
 
 We have already investigated several hundred terrestrial and marine 
            plants for their chemical and biological significance and isolated 
            and identified over 2000 compounds of which some 600 turned out to 
            be new and novel compounds with potential to be developed as medicines. 
            In order to optimize the chances of finding novel leads, extensive 
            primary biological screening and activity-guided fractionation and 
            purification were carried out. State-of-the-art spectroscopic techniques, 
            especially modern multi-dimensional NMR techniques, were utilized 
            to elucidate the structures of bioactive natural molecules, rapidly 
            and accurately. The bioassay protocols include antibacterial, antifungal, 
            cytotoxicity, phytotoxicity, insecticidal, antileishmanial, antioxidant 
            and enzyme inhibition activities. The results so far have been truly 
            exciting as we have identified several new classes of potent cholinesterase, 
            urease, phosphodiesterase, glucuronidase, and prolyl endopeptidase 
            inhibitors. A large number of antioxidant secondary metabolites have 
            also been identified. In the majority of cases, chemical and microbial 
            derivatizations were carried out to study the structure-activity relationships.
 
 A selection of these results illustrated by their potential application 
            to treat diseases such as epilepsy will be presented. Synthetic approaches 
            to bioactive anti-cancer compounds will also be presented.
 
 
 
 
 
 
 
 
 
 
 
 
 
 |